Finally, in an IDH-mutated glioma model, R-2-HG produced by tumor cells was taken up by local T cells in a paracrine fashion and inhibited T cell proliferation and cytokine production, suggesting a role for IDH mutations in driving immune dysregulation in the tumor microenvironment, further contributing to oncogenesis [46]. Here, IDH2 is linked to central nervous system cancer.